BioDea

What BioDea does

BioDea is a privately held Italian biotechnology-related company headquartered in Civitella in Val di Chiana, in the province of Arezzo, Tuscany. It was founded in 2015 and operates with a small team of 11-50 employees according to the available firmographic record. The corporate name and the use of a .bio top-level domain are consistent with a positioning in the biological sciences, though the specific sub-vertical (e.g., agricultural biotech, industrial biotech, environmental biotech, or bio-based products) cannot be confirmed from the provided data.

The primary commercial and technical details of BioDea could not be verified in the input: the company website (https://www.biodea.bio/) returned only a loading/verification page rather than substantive content, and structured product, technology, customer, pricing, partnership, and funding fields were either empty or marked as unavailable. Consequently, the company's core products, underlying scientific or technological platform, intellectual property portfolio, customer segments, and revenue model are not established in the evidence base.

As a result, the company's business model, go-to-market approach, and unit economics cannot be characterized. No named investors, funding rounds, executive team, certifications, regulatory actions, or strategic transactions were disclosed. BioDea should be treated as a data-thin entity for investment analysis purposes; further first-party diligence (direct outreach, cap-table review, and product demonstration) would be required before any substantive commercial or financial conclusions can be drawn.

Name

BioDea

Website

https://biodea.bio

Company type

Private

Founded year

2015

Headcount range

11–50 employees

Short description

BioDea is a privately held Italian biotechnology company founded in 2015, headquartered in Civitella in Val di Chiana, Arezzo, with 11-50 employees. Specific products, technology, and customer focus could not be verified from available sources.

Ownership category

akta.pro rank

Product category

Biotechnology

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro industry

PRIMARYHLAGADAB

Method Development & Validation (ICH/USP)

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Laboratory Testing & Analytical Services

SECONDARYHLAAAIAD

Synthetic Biology & Genetic Circuit Design Platforms (pathway engineering, chassis development)

Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)

SECONDARYHLAGAHAF

Small-Molecule Analytical Development & Method Validation (CMC)

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services

Keywords

• Biotechnology products
• Bio-based solutions
• Agricultural biology
• Life sciences research
• Biological inputs

Headquarters

HQ city

Civitella in Val di Chiana, Arezzo

HQ country

Italy

HQ region

Europe

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel

Core offering

BioDea's core offering cannot be determined from the available source data. The input contains only firmographic metadata and a website loading/verification page ("One moment, please... Loader... Please wait while your request is being verified...") that does not provide any substantive information about what the company fundamentally does or sells.

Differentiator

Problem solved

Functional benefit

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Emerging players

• Novamont: Italian bioeconomy / bio-based chemicals company of comparable domestic scale and orientation toward biological product development, making it a natural regional comparand for an Arezzo-based Italian biotech.

Broad incumbents

• Eurofins Scientific: Global leader in bioanalytical and life-science testing services with extensive specialty method development offerings — directly relevant if BioDea operates in biological analytical services.
• Charles River Laboratories: Major CDMO/CRO with biological product development and analytical services — comparable in method-development and biological characterization offerings, though at vastly greater scale.
• Mérieux NutriSciences: Food and bioanalytical testing services provider with agri-food and biological testing offerings; relevant peer for biological analytical / method-development services in the food-agri biotech adjacency.
• SGS: Global testing, inspection, and certification company with life-sciences and agri-food laboratory service lines; broadly competes in the same bioanalytical / method-validation space.

Others

• Sartorius AG: Bioprocessing and lab-tools supplier to biotech R&D and biological-product manufacturers; thematically connected via the bio-innovation stack BioDea would purchase from and sell into.

Market position

Strengths3 records

Weaknesses3 records

Key risks4 records

Key highlights3 records

Customer concentration

• LinkedInlinkedin.com/company/biodea

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BioDea